Sarcomere protein gene mutations and inherited heart disease: A β cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure

Novartis Foundation Symposium

Volumn 274, Issue , 2006, Pages 176-189

  Kamisago, Mitsuhiro ^a,c   Schmitt, Joachim P ^d   McNamara, Dennis ^e   Seidman, Christine ^a,b   Seidman, J G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; VENTRICULAR MYOSIN;

ADULT; ANIMAL; CARDIOMYOPATHY; CHEMICAL STRUCTURE; CONFORMATION; CONGESTIVE HEART FAILURE; ENDOCARDIAL FIBROELASTOSIS; FAMILY HEALTH; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MUTATION; PATHOLOGY; REVIEW; SARCOMERE;

ADULT; ANIMALS; CALCIUM; CARDIOMYOPATHIES; ENDOCARDIAL FIBROELASTOSIS; FAMILY HEALTH; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MUTATION; SARCOMERES; VENTRICULAR MYOSINS;

EID: 39049192918     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (37)

1. Arad M, Benson DW, Perez-Atayde AR et al 2002 Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 109:357-362
2. Arad M, Maron BJ, Gorham JM et al 2005 Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352:362-372
3. Chen S, Thompson MW, Rose V 1971 Endocardial fibroelastosis: family studies with special reference to counseling. J Pediatr 79:385-392
4. Colluci WS, Braunwald EB (eds) 1997 Pathophysiology of heart failure. Heart disease. Saunders, Philadelphia, p394-420
5. D'Adamo P, Fassone L, Gedeon A et al 1997 The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 61:862-867
6. Fatkin D, Graham RM 2002 Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 82:945-980
7. Fatkin D, McConnell BK, Mudd JO et al 2000 An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin Invest 106:1351-1359
8. Frey N, Olson EN 2003 Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45-79
9. Friedman WF 1997 Heart disease: A textbook of cardiovascular medicine. E. Braunwald, W. B. Saunders Company, Philadelphia p 991-992
10. Geisterfer-Lowrance AA, Christe M, Conner DA et al 1996 A mouse model of familial hypertrophic cardiomyopathy. Science 272:731-734
11. Griffin ML, Hernandez A, Martin TC et al 1988 Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 11:139-144
12. Hanukoglu A, Fried D, Somekh E 1986 Inheritance of familial primary endocardial fibroelastosis. Clin Pediatr (Phila) 25:272-275
13. Hunter AS, Keay AJ 1973 Primary endocardial fibroelastosis. An inherited condition. Arch Dis Child 48:66-69
14. Kamisago M, Sharma SD, DePalma SR et al 2000 Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343:1688-1696
15. Karkkainen S, Helio T, Jaaskelainen P et al 2004 Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy. Eur J Heart Fail 6:861-868
16. Keller DI, Coirault C, Rau T et al 2004 Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties. J Mol Cell Cardiol 36:355-362
17. Manning JA, Sellers FJ, Bynum RS, Keith JD 1964 The medical management of clinical endocardial fibroelastosis. Circulation 29:60-65
18. McConnell BK, Fatkin D, Semsarian C et al 2001 Comparison of two murine models of familial hypertrophic cardiomyopathy. Circ Res 88:383-389
19. McKinsey TA, Olson EN 2004 Cardiac histone acetylation-therapeutic opportunities abound. Trends Genet 20:206-213
20. Minarovic I, Meszaros LG 1998 Fluorescent probing with felodipine of the dihydropyridine receptor and its interaction with the ryanodine receptor calcium release channel. Biochem Biophys Res Commun 244:519-524
21. Mohapatra B, Jimenez S, Lin JH 2003 Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab 80:207-215
22. Niimura H, Bachinski LL, Sangwatanaroj S et al 1998 Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338:1248-1257
23. Niimura H, Patton KK, McKenna WJ et al 2002 Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105:446-451
24. Palmer BM, Fishbaugher DE, Schmitt JP 2004 Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium. Am J Physiol Heart Circ Physiol 287:H91-99
25. Palmiter KA, Tyska MJ, Haeberle JR, Alpert NR, Fananapazir L, Warshaw DM 2000 R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level. J Muscle Res Cell Motil 21:609-620
26. Romero M, Sanchez I, Pujol MD 2003 New advances in the field of calcium channel antagonists: cardiovascular effects and structure-activity relationships. Curr Med Chem Cardiovasc Hematol Agents 1:113-141
27. Schonberger J, Seidman CE 2001 Many roads lead to a broken heart: the genetics of dilated cardiomyopathy. Am J Hum Genet 69:249-260
28. Seidman JG, Hirschhorn J, Benjamin E et al 2005 Cardiogenomics: Program in genomic applications. http://cardiogenomics.med.harvard.edu/home
29. Seidman JG, Seidman C 2001 The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104:557-567
30. Semsarian C, Ahmad I, Giewat M 2002 The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J Clin Investig 109:1013-1020
31. Shimizu M, Ino H, Yasuda T 2005 Gene mutations in adult Japanese patients with dilated cardiomyopathy. Circ J 69:150-153
32. Towbin JA, Bowles NE 2001 Molecular genetics of left ventricular dysfunction. Curr Mol Med 1:81-90
33. Tyska MJ, Hayes E, Giewat M, Seidman CE, Seidman JG, Warshaw DM 2000 Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ Res 86:737-744
34. Valdes-Dapena M, Gilbert-Barness E 2002 Cardiovascular causes for sudden infant death. Pediatr Pathol Mol Med 21:195-211
35. Villard E, Duboscq-Bidot L, Charron P et al 2005 Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J 26:794-803
36. Wehrens XH, Lehnart SE, Marks AR 2005 Intracellular calcium release and cardiac disease. Annu Rev Physiol 67:69-98
37. Westwood M, Harris R, Burn JL, Barson AJ 1975 Heredity in primary endocardial fibroelastosis. Br Heart J 37:1077-1084